Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...

Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses new real-world data showing that most high-risk ...

What was once considered a competitive advantage for forward-thinking commercial teams has now become essential for success ...

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the pharmaceutical industry. The goal of the policy is for Americans to pay prices ...

Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how repurposing GLP-1s and ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...

Stricter regulations on a fragmented media landscape is forcing the industry to rethink marketing.

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

The 700,000 square-foot facility is expected to create 400 high-wage manufacturing jobs once operational.